Tromsø
WP4: Advancing oncological PET imaging using machine learning
The work package on machine learning will develop data analysis methods in support of the other work packages. The aim is to use expertise in artificial intelligence to help solving…
Read MoreWP3: Phagocyte targeting in breast cancer
In spite of an enormous global research effort, astonishing preclinical cancer cures, and the approval of multiple formulations, nanomedicine’s impact on cancer patient care remains limited. Recently, it is becoming…
Read MoreWP2: Radionuclide targeted therapy and imaging in Glioblastoma
The plasticity of GB tumor cells and their ability to infiltrate adjoining brain tissue limits the effectiveness of current cancer therapies. Microglia plays an important role in GB progression. Inhibition…
Read MoreWP1: Immuno-PET and lung cancer
Despite the demonstrated effectiveness of immunoregulatory agents such as immune checkpoint blockers (ICB) on refractory cancers, these therapies work satisfactorily only in a reduced subset of patients. Further, ICB treatments…
Read More